Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Array Biopharma Inc (NASDAQ:ARRY)

3.23
Delayed Data
As of 3:59pm ET
 -0.15 / -4.44%
Today’s Change
2.38
Today|||52-Week Range
6.04
-23.46%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues69.6M42.1M51.9M137.9M
 
 
 
 
 
Cost of Goods Sold25.7M41.5M40.7M23.2M
 
 
 
 
 
Depreciation And Amortization4.4M4.5M3.7M--
 
 
 
 
 
Operating ExpensesGross Income39.5M-3.9M7.5M114.7M
 
 
 
 
 
General Expenses78.6M68.9M85.9M196.9M
 
 
 
 
 
Research And Development59.4M47.6M54.4M160.7M
 
 
 
 
 
Total Operating Expenses108.7M114.9M130.3M220.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-39.1M-72.8M-78.4M-82.2M
 
 
 
 
 
Extraordinary Credit656.0K0.0080.0M0.00
 
 
 
Extraordinary Charge-12.0M-2.8M--0.00
 
 
 
Interest Expense On Debt11.5M9.7M10.2M10.9M
 
 
 
 
 
Other Expenses0.000.0017.9M0.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-61.9M-85.3M9.4M-92.8M
 
 
 
 
 
Net Income-61.9M-85.3M9.4M-92.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS107.8M123.4M136.7M143.0M
 
 
 
 
 
Shares To Calculate EPS Diluted107.8M123.4M141.7M143.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.57-$0.69$0.07-$0.65
 
 
 
 
 
EPS Diluted-$0.57-$0.69$0.07-$0.65